Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy.

Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy.
复制标题

癌症细胞疗法的峰会:多个学科相互作用在推进临床治疗方面的重要性。

DOI:
10.1186/1479-5876-9-107
复制
发表时间:
2011-07-08
影响因子:
7.4
通讯作者:
Stroncek DF
Stroncek DF
中科院分区:
医学2区
文献类型:
--
作者:
Melief CJ;O'Shea JJ;Stroncek DF

文献摘要

参考文献

相似文献

癌症的细胞治疗领域正在迅速发展,其进展所涉及的问题是复杂和广泛的。过继性细胞治疗癌症的临床应用和成功的增长是由于免疫学、癌症生物学、基因治疗和干细胞生物学的快速发展以及这些领域的进展从研究实验室到临床的转化。这一领域的持续发展取决于这些不同学科之间的思想交流,在研究实验室和动物模型中测试新想法,开发新的细胞疗法和GMP方法来生产这些疗法,以及在临床试验中测试新的过继细胞疗法。2011年11月1日和2日在美国国立卫生研究院(NIH)校园举行的癌症细胞疗法峰会将包括与过继细胞疗法相关的观点,概念和想法,这些观点通常不会在任何一次会议上一起提出。这种新颖的组装将产生新的想法和新的合作,并可能提高这一领域的进步速度。
The field of cellular therapy of cancer is moving quickly and the issues involved with its advancement are complex and wide ranging. The growing clinical applications and success of adoptive cellular therapy of cancer has been due to the rapid evolution of immunology, cancer biology, gene therapy and stem cell biology and the translation of advances in these fields from the research laboratory to the clinic. The continued development of this field is dependent on the exchange of ideas across these diverse disciplines, the testing of new ideas in the research laboratory and in animal models, the development of new cellular therapies and GMP methods to produce these therapies, and the testing of new adoptive cell therapies in clinical trials. The Summit on Cell Therapy for Cancer to held on November 1 and 2, 2011 at the National Institutes of Health (NIH) campus will include a mix of perspectives, concepts and ideas related to adoptive cellular therapy that are not normally presented together at any single meeting. This novel assembly will generate new ideas and new collaborations and possibly increase the rate of advancement of this field.
DOI: 10.1126/science.1129003
发表时间: 2006-10-06
期刊: SCIENCE
影响因子: 56.9
作者:
Morgan, Richard A.;Dudley, Mark E.;Rosenberg, Steven A.
通讯作者: Rosenberg, Steven A.
DOI: 10.1111/j.1537-2995.2006.01145.x
发表时间: 2007-03-01
期刊: TRANSFUSION
影响因子: 2.9
作者:
McKenna, D. H.;Sumstad, D.;Miller, J. S.
通讯作者: Miller, J. S.
DOI: 10.1182/blood-2010-04-281931
发表时间: 2010-11-18
期刊: BLOOD
影响因子: 20.3
作者:
Kochenderfer, James N.;Wilson, Wyndham H.;Rosenberg, Steven A.
通讯作者: Rosenberg, Steven A.
DOI: 10.1158/0008-5472.can-10-2288
发表时间: 2010-11-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Ly, Long V.;Sluijter, Marjolein;van Hall, Thorbald
通讯作者: van Hall, Thorbald
DOI: 10.1158/1078-0432.ccr-10-0041
发表时间: 2010-05-01
影响因子: 11.5
作者:
Besser, Michal J.;Shapira-Frommer, Ronnie;Schachter, Jacob
通讯作者: Schachter, Jacob